OCT SoCal 2026: AI Know-How, Responsible Use, and the Virtues in Taking Ownership
OVERVIEWThe OCT (Outcomes Conference & Training) Southern California 2026 conference highlighted the growing role of AI in clinical trials, with emphasis on responsible use practices and the importance of stakeholder ownership in AI deployment and governance. Sessions focused on how AI can accelerate trial design, patient recruitment, and data analysis, while also addressing risks of over-reliance on AI, the need for human expertise in interpreting AI recommendations, and the importance of transparency with trial participants about AI involvement. The conference underscored that responsible AI use in clinical research requires active engagement from researchers, sponsors, regulators, and participants—not passive acceptance of AI recommendations. Key themes included: (1) AI know-how as a competency clinical research professionals must develop; (2) The distinction between AI as a tool (augmenting human judgment) versus AI as a decision-maker (replacing human judgment); (3) The importance of clear communication about AI's role and limitations to trial participants and stakeholders. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.